Cantitate/Preț
Produs

Current Directions in Radiopharmaceutical Research and Development: Developments in Nuclear Medicine, cartea 30

Editat de Steven J. Mather
en Limba Engleză Hardback – 30 sep 1996
Radiophannaceutical research has recently undergone a major change in direction. In past years it has been concerned mainly with the development of perfusion tracers, the biodistribution of which reflect the regional blood flow to areas of major organs such as the heart and brain. However, a major new direction of interest now lies in the development of receptor-binding radio-tracers which can be used to perform in-vivo characterisation of diseased tissues and it is likely that much of the future research in this field will follow this direction. The difficulties in developing such tracers are considerable. The researcher must first identify a promising target for radiopharmaceutical development. High specific activity radioactive molecules must be designed and synthesised which will both bind to the target receptor with high affinity, and also have the physicochemical characteristics which will allow them to reach the target site in sufficient quantity while at the same time showing minimal uptake in non-target tissues. Thus the knowledge base required for radiophannaceutical development has now expanded beyond the limits of radiopharmaceutical chemistry to include aspects of biochemistry, molecular biology and conventional drug design. The portfolio of basic knowledge required to support current radiopharmaceutical development is changing and scientists working in this arena need to be trained in this regard. At the same time, the very latest developments in the field need to be communicated to the scientific community in order to stimulate the advancement of this exciting new direction of research.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 103447 lei  6-8 săpt.
  SPRINGER NETHERLANDS – 20 sep 2011 103447 lei  6-8 săpt.
Hardback (1) 104004 lei  6-8 săpt.
  SPRINGER NETHERLANDS – 30 sep 1996 104004 lei  6-8 săpt.

Din seria Developments in Nuclear Medicine

Preț: 104004 lei

Preț vechi: 109477 lei
-5% Nou

Puncte Express: 1560

Preț estimativ în valută:
19908 21405$ 16596£

Carte tipărită la comandă

Livrare economică 19 decembrie 24 - 02 ianuarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780792342540
ISBN-10: 0792342542
Pagini: 240
Ilustrații: XVI, 240 p.
Dimensiuni: 156 x 234 x 20 mm
Greutate: 0.51 kg
Ediția:1996
Editura: SPRINGER NETHERLANDS
Colecția Springer
Seria Developments in Nuclear Medicine

Locul publicării:Dordrecht, Netherlands

Public țintă

Research

Cuprins

1. Radiopharmaceutically relevant chemistry of technetium and rhenium..- 2. Bifunctional chelators for Tc-99m.- 3. Medium half-life inorganic radionuclides for PET imaging.- 4. Therapeutic radionuclides: making the right choice..- 5. Radiopharmaceuticals for imaging hypoxia.- 6. Genetic engineering of monoclonal antibodies.- 7. The development of radiopharmaceuticals for imaging CNS receptors.- 8. Imaging the functions of the cell nucleus..- 9. Steroid hormone receptors as targets for diagnostic imaging.- 10. Radiolabelling oligonucleotides with imagable radionuclides.- 11. Radioligand binding assays: theory and practice.- 12. Molecular modelling: an introduction.- 13. Computer modelling of metal-based radiopharmaceuticals.- 14. Microautoradiography.

Recenzii

` ... very good reference text ... a very useful book, especially as an aid to teachers or in providing an overall picture of fast developing new didrections in radiopharmaceutical research.'
ANZ Nuclear Medicine, 23 (1997)